(Q44936481)

7 December 2017

Quantitative EBV viral loads and immunosuppression alterations can decrease PTLD incidence in pediatric liver transplant recipients (English)

1 reference

7 December 2017

1 reference

1 reference

3

Cliona M Rooney

1 reference

7 December 2017

4

Helen E Heslop

1 reference

7 December 2017

2

Barbara Savoldo

1 reference

7 December 2017

5

Adrian P Gee

1 reference

7 December 2017

11

John A Goss

1 reference

7 December 2017

7

Neal R Barshes

1 reference

7 December 2017

6

Yvette Caldwell

1 reference

7 December 2017

8

Jaymee D Scott

1 reference

7 December 2017

Timothy C Lee

1

1 reference

7 December 2017

Lisa J Bristow

series ordinal

9

1 reference

7 December 2017

Christine A O'Mahony

series ordinal

10

1 reference

7 December 2017

language of work or name

English

0 references

publication date

1 September 2005

1 reference

American Journal of Transplantation

7 December 2017

7

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

7 December 2017

5

1 reference

7 December 2017

9

1 reference

7 December 2017

2222-2228

1 reference

Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection

7 December 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01002.X

Epstein-Barr virus-related lymphoproliferation in children after liver transplant: role of immunity, diagnosis, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01002.X

Prevention and preemptive therapy of postransplant lymphoproliferative disease in pediatric liver recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01002.X

The role of antiviral and immunoglobulin therapy in the prevention of Epstein-Barr virus infection and post-transplant lymphoproliferative disease following solid organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01002.X

Successful treatment of posttransplantation lymphoproliferative disorder (PTLD) following renal allografting is associated with sustained CD8(+) T-cell restoration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01002.X

Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01002.X

Successful treatment of posttransplant lymphoproliferative disease with prolonged rituximab treatment in intestinal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01002.X

Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01002.X

Predictive negative value of persistent low Epstein-Barr virus viral load after intestinal transplantation in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01002.X

Toward standardization of Epstein-Barr virus DNA load monitoring: unfractionated whole blood as preferred clinical specimen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01002.X

Reduced incidence of Epstein-Barr virus-associated posttransplant lymphoproliferative disorder using preemptive antiviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01002.X

Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus In vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01002.X

Rational management of posttransplant lymphoproliferative disorder in pediatric recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01002.X

10.1111/J.1600-6143.2005.01002.X

21 January 2018

Identifiers

DOI

1 reference

7 December 2017

1 reference